SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 11)
COOPER LIFE SCIENCES, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
216712109
(CUSIP Number)
Emanuel J. Adler
Tenzer Greenblatt LLP
405 Lexington Avenue
New York, New York 10174
(212) 885-5565
(Name, Address and Telephone Number of Person
Authorized to Receive Notice and Communications)
May 18, 1998
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d- 1(a) for other parties to whom copies are to
be sent.
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 6 Pages
<PAGE>
SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO. 216712109 Page 2 of 6 Pages
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MOSES MARX
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)|_|
(b)|_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,106,120*
SHARES
BENEFICIALLY -------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING ----
PERSON -------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
1,106,120*
-------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
----
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,106,120*
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
52%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING
EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
- --------------------
* Includes 125,000 shares of Common Stock reported herein as also being
beneficially owned by Momar Corp.
Page 2 of 6 Pages
<PAGE>
SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO. 216712109 Page 3 of 6 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MOMAR CORP.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
MARYLAND
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 125,000
SHARES -------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH ----
REPORTING
PERSON -------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
125,000
-------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
----
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
125,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.87%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING
EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 3 of 6 Pages
<PAGE>
This Amendment No. 11 amends and supplements the Schedule 13D, as amended
and supplemented by Amendments Nos. 1 through 10, inclusive (the "Schedule
13D"), heretofore filed by the Reporting Persons with the Securities and
Exchange Commission with respect to the Common Stock ("Common Stock") of Cooper
Life Sciences, Inc., a Delaware corporation (the "Company"). Except as amended
hereby, there has been no change in the information contained in the Schedule
13D.
Item 5. Interest in Securities of the Issuer.
(a) - (b)
According to the Company's Quarterly Report on Form 10- Q for the
period ending January 31, 1998, there were 2,126,265 shares of Common
Stock outstanding on March 13, 1998.
Moses Marx
As of the date of this Amendment No. 11 Moses Marx beneficially owned
1,106,120 shares of Common Stock, representing 52% (calculated in
accordance with the instructions to Schedule 13D) of the issued and
outstanding shares of the Common Stock. Said securities consist of (i)
980,620 shares owned directly by Mr. Marx; (ii) 125,000 shares owned
of record by Momar; and (iii) 500 options to purchase 500 shares of
Common Stock. With respect to the shares described in clause (ii), Mr.
Marx may be deemed to be a beneficial owner of such shares by virtue
of his being the only person in a position to determine the investment
and voting decisions of Momar with respect to such shares.
Mr. Marx has the sole power to vote and dispose of all such shares.
Page 4 of 6 Pages
<PAGE>
Momar
Momar owns 125,000 shares of Common Stock, comprising 5.87% of the
issued and outstanding shares of the Common Stock.
Momar has the sole power to vote and dispose of all such shares.
(c) On May 18, 1998, Mr. Marx donated 100,000 shares of Common Stock
to Terumah Foundation, a 501(c)(3) tax exempt organization.
Other than as set forth above, during the last 60 days, neither Mr.
Marx nor Momar effected any transactions in the Shares.
(d) Each of the Reporting Persons affirms that no person other than
the Reporting Persons has the right to receive, or the power to direct
the receipt of dividends from, or the proceeds from the sale of, the
Common Stock owned by the Reporting Persons.
(e) It is inapplicable for the purposes herein to state the date on
which the Reporting Persons ceased to be the owners of more than five
percent of the Common Stock.
Page 5 of 6 Pages
<PAGE>
SIGNATURE
After reasonable inquiry, and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Date: June 10, 1998
/s/ Moses Marx
----------------------------------
MOSES MARX
MOMAR CORP.
By: /s/ Moses Marx
-----------------------------
Moses Marx, President
Page 6 of 6 Pages
